Stocks
REGENXBIO (RGNX) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 17.4% | 17.9% | 0.00% | 27.3% | 11.0% | 6.57% | |||
| Changes by years, y/y, % | -16pp | +1pp | -18pp | -16pp | +12.7% | ||||
REGENXBIO. CAPEX/Revenue, %
REGENXBIO. CAPEX/Revenue, changes, pp
REGENXBIO (RGNX) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| CAPEX/Revenue, % | 25.2% | 12.9% | 4.98% | 5.07% | 3.57% | 6.57% | ||
| Changes by years, y/y, % | -24pp | -15pp | -14pp | -12pp | -22pp | |||
| Changes by quarters, q/q, % | +8pp | -12pp | -8pp | +0pp | -2pp | |||
